Nexium gastro-resistant tablets

Nexium is a well-known brand of medication used to treat conditions caused by excess stomach acid, such as gastroesophageal reflux disease (GERD). The active ingredient, Esomeprazole, was developed by the Swedish pharmaceutical company AstraZeneca. This specific packaging is in Portuguese, intended for the Portuguese market, and features the branding of Grünenthal, which handles the distribution and commercial rights for the product in several European regions.

While the brand was originally founded and developed in Sweden, manufacturing for the European market takes place across several sites, most notably in AstraZeneca's facilities in Sweden and France. The ultimate ownership and trademark management reside with AstraZeneca, a British-Swedish multinational pharmaceutical company, though local distribution often partners with companies like Grünenthal to manage the logistics and sales within specific territories like Portugal.